DNA Methylation as Drug Sensitivity Marker in RCC: A Systematic Review
DNA Methylation as Drug Sensitivity Marker in RCC: A Systematic Review
About this item
Full title
Author / Creator
Publisher
Switzerland: MDPI AG
Journal title
Language
English
Formats
Publication information
Publisher
Switzerland: MDPI AG
Subjects
More information
Scope and Contents
Contents
Patient response after treatment of renal cell cancer (RCC) with systemic agents, which include various drug categories, is generally poor and unpredictable. In this context, the ideal drug administration includes tools to predict the sensitivity of the disease to therapy. The aim of this study was to systematically summarize the reports on the pre...
Alternative Titles
Full title
DNA Methylation as Drug Sensitivity Marker in RCC: A Systematic Review
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_2d342764c7074b22bb42f758bfedd20d
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_2d342764c7074b22bb42f758bfedd20d
Other Identifiers
ISSN
2075-4655
E-ISSN
2075-4655
DOI
10.3390/epigenomes8030028
